Bioresorbable and biodegradable technology in stents along with iterative improvements in TAVR rounded out the top five “game-changers” in cardiology in 2015.
Forty-six cardiologists responded to the question:
“What is the research reported in 2015 that had the greatest impact on clinical practice,” and based on their responses here are the top five:
1. SPRINT Trial
2. PCSK9 inhibitors approval
3. Entresto approval